Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: BMC Musculoskeletal Disorders (2020) 21:109 https://doi.org/10.1186/s12891-020-3137-4
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2021
- Urheber
-
Weissenberger, M.
Weissenberger, M. H.
Gilbert, F.
Groll, J.
Evans, C. H.
Steinert, A. F.
- DOI
-
10.1186/s12891-020-3137-4
- URN
-
urn:nbn:de:bvb:20-opus-229232
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weissenberger, M.
- Weissenberger, M. H.
- Gilbert, F.
- Groll, J.
- Evans, C. H.
- Steinert, A. F.
- Universität Würzburg
Entstanden
- 2021
Ähnliche Objekte (12)
Benign prostatic hypertrophy
Attenuation of hypertrophy in chondrogenically differentiating human mesenchymal stem cells via treatment with a retinoic acid receptor inverse agonist
Reprogramming of mesenchymal stem cells and adult fibroblasts following nuclear transfer in rabbits
First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
Comparative in vitro treatment of mesenchymal stromal cells with GDF-5 and R57A induces chondrogenic differentiation while limiting chondrogenic hypertrophy
Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Optimization of Scaffolds for the Delivery of Mesenchymal Stem Cells into Dermal Wounds
Nasal delivery of mesenchymal stem cell - derived mitochondria for resolving chemotherapy-induced cognitive deficits
Lipid metabolism adaptations are reduced in human compared to murine Schwann cells following injury
Advancing tendon healing by scaffolds-free delivery of different subtypes of mesenchymal stem or progenitor cells
Benign prostatic hypertrophy
Attenuation of hypertrophy in chondrogenically differentiating human mesenchymal stem cells via treatment with a retinoic acid receptor inverse agonist
Reprogramming of mesenchymal stem cells and adult fibroblasts following nuclear transfer in rabbits
First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
Comparative in vitro treatment of mesenchymal stromal cells with GDF-5 and R57A induces chondrogenic differentiation while limiting chondrogenic hypertrophy
Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Optimization of Scaffolds for the Delivery of Mesenchymal Stem Cells into Dermal Wounds
Nasal delivery of mesenchymal stem cell - derived mitochondria for resolving chemotherapy-induced cognitive deficits
Lipid metabolism adaptations are reduced in human compared to murine Schwann cells following injury
Advancing tendon healing by scaffolds-free delivery of different subtypes of mesenchymal stem or progenitor cells
Benign prostatic hypertrophy
Attenuation of hypertrophy in chondrogenically differentiating human mesenchymal stem cells via treatment with a retinoic acid receptor inverse agonist
Reprogramming of mesenchymal stem cells and adult fibroblasts following nuclear transfer in rabbits
First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
Comparative in vitro treatment of mesenchymal stromal cells with GDF-5 and R57A induces chondrogenic differentiation while limiting chondrogenic hypertrophy
Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Optimization of Scaffolds for the Delivery of Mesenchymal Stem Cells into Dermal Wounds
Nasal delivery of mesenchymal stem cell - derived mitochondria for resolving chemotherapy-induced cognitive deficits
Lipid metabolism adaptations are reduced in human compared to murine Schwann cells following injury